Why this grouping
These entries are kept as separate Disease entries because their proximal lesions are distinct: UGDH limits UDP-glucuronic acid supply for glycosaminoglycan/proteoglycan and glycolipid production; UGP2 limits UDP-glucose-dependent glycogen and protein glycosylation biology in brain; and UGGT1 disrupts ER reglucosylation-based quality control of N-linked glycoproteins. They are grouped only at the pathway-placement level as "other/multiple glycosylation pathway" disorders rather than merged into a single disease entity.
Membership criteria
NECESSARY (member ⇒ criteria)
A member has a primary lesion in a nucleotide-sugar precursor pathway, glycosaminoglycan/proteoglycan biosynthesis, or ER N-glycoprotein quality control that affects more than one downstream glycan or glycoprotein client class.
- OR
Multiple-pathway glycosylation defects represented by precursor supply, glycosaminoglycan biosynthesis, N-linked glycosylation, or ER folding quality control.
- HAS BIOLOGICAL PROCESS
glycosaminoglycan biosynthetic process GO:0006024
Impairs glycosaminoglycan biosynthesis.
- HAS BIOLOGICAL PROCESS
protein O-linked glycosylation GO:0006493
Impairs protein O-linked glycosylation.
- HAS BIOLOGICAL PROCESS
protein N-linked glycosylation GO:0006487
Perturbs protein N-linked glycosylation.
- HAS BIOLOGICAL PROCESS
protein folding in endoplasmic reticulum GO:0034975
Perturbs ER protein-folding quality control.
- HAS BIOLOGICAL PROCESS
glycosaminoglycan biosynthetic process GO:0006024
Coverage and gaps
3 rows
1 contradiction
Exact MONDO scope not assessed
3 listed with MONDO ID
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Impairs glycosaminoglycan biosynthesis. GO:0006024 | C1.2 Impairs protein O-linked glycosylation. GO:0006493 | C1.3 Perturbs protein N-linked glycosylation. GO:0006487 | C1.4 Perturbs ER protein-folding quality control. GO:0034975 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
UGGT1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismUGGT1 variants impair reglucosylation and ER retention of the UDP-glucose:glycoprotein glucosyltransferase quality-control enzyme for N-linked glycoproteins.
UGGT1 hgnc:15663protein folding in endoplasmic reticulum GO:0034975
|
UGGT1-congenital disorder of glycosylation
MONDO:0980705
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED |
| listed with MONDO ID |
UGP2-related developmental and epileptic encephalopathy 83
DISEASE
Differentiating mechanismUGP2 short-isoform loss in brain reduces UDP-glucose production in neural stem cells, affecting glycogen metabolism, glycosylation, and ER proteostasis.
UGP2 hgnc:12527protein N-linked glycosylation GO:0006487
|
developmental and epileptic encephalopathy, 83
MONDO:0032895
|
yes | yes | not assessed | listed | contradiction | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
UGDH-related developmental and epileptic encephalopathy 84
DISEASE
Differentiating mechanismUGDH loss reduces conversion of UDP-glucose to UDP-glucuronic acid, limiting precursor supply for glycosaminoglycan-rich proteoglycans and glycolipids.
UGDH hgnc:12525glycosaminoglycan biosynthetic process GO:0006024
|
developmental and epileptic encephalopathy, 84
MONDO:0032918
|
yes | yes | not assessed | listed | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Other Disorders of Multiple Glycosylation Pathways
display_name: Other Disorders of Multiple Glycosylation Pathways
creation_date: "2026-07-06T06:04:18Z"
description: >-
This grouping collects rare inherited glycosylation disorders in which the
primary lesion is not a single canonical N-glycan assembly enzyme or Golgi
processing enzyme, but instead affects nucleotide-sugar precursor supply or
ER glycoprotein quality control with consequences across multiple glycan or
glycoprotein pathways. The work-package members are UGDH-related DEE84,
UGP2-related DEE83, and UGGT1-CDG.
grouping_basis:
- SHARED_PATHWAY
grouping_rationale: >-
These entries are kept as separate Disease entries because their proximal
lesions are distinct: UGDH limits UDP-glucuronic acid supply for
glycosaminoglycan/proteoglycan and glycolipid production; UGP2 limits
UDP-glucose-dependent glycogen and protein glycosylation biology in brain;
and UGGT1 disrupts ER reglucosylation-based quality control of N-linked
glycoproteins. They are grouped only at the pathway-placement level as
"other/multiple glycosylation pathway" disorders rather than merged into a
single disease entity.
membership_criteria:
- description: >-
A member has a primary lesion in a nucleotide-sugar precursor pathway,
glycosaminoglycan/proteoglycan biosynthesis, or ER N-glycoprotein quality
control that affects more than one downstream glycan or glycoprotein client
class.
criteria_semantics: NECESSARY
logic:
operator: OR
description: >-
Multiple-pathway glycosylation defects represented by precursor supply,
glycosaminoglycan biosynthesis, N-linked glycosylation, or ER folding
quality control.
operands:
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: Impairs glycosaminoglycan biosynthesis.
biological_processes:
- preferred_term: glycosaminoglycan biosynthetic process
term:
id: GO:0006024
label: glycosaminoglycan biosynthetic process
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: Impairs protein O-linked glycosylation.
biological_processes:
- preferred_term: protein O-linked glycosylation
term:
id: GO:0006493
label: protein O-linked glycosylation
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: Perturbs protein N-linked glycosylation.
biological_processes:
- preferred_term: protein N-linked glycosylation
term:
id: GO:0006487
label: protein N-linked glycosylation
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: Perturbs ER protein-folding quality control.
biological_processes:
- preferred_term: protein folding in endoplasmic reticulum
term:
id: GO:0034975
label: protein folding in endoplasmic reticulum
members:
- member: UGDH-related developmental and epileptic encephalopathy 84
member_type: DISEASE
differentiating_mechanisms:
- description: >-
UGDH loss reduces conversion of UDP-glucose to UDP-glucuronic acid,
limiting precursor supply for glycosaminoglycan-rich proteoglycans and
glycolipids.
gene:
preferred_term: UGDH
term:
id: hgnc:12525
label: UGDH
biological_processes:
- preferred_term: glycosaminoglycan biosynthetic process
modifier: DECREASED
term:
id: GO:0006024
label: glycosaminoglycan biosynthetic process
- member: UGP2-related developmental and epileptic encephalopathy 83
member_type: DISEASE
differentiating_mechanisms:
- description: >-
UGP2 short-isoform loss in brain reduces UDP-glucose production in neural
stem cells, affecting glycogen metabolism, glycosylation, and ER
proteostasis.
gene:
preferred_term: UGP2
term:
id: hgnc:12527
label: UGP2
biological_processes:
- preferred_term: protein N-linked glycosylation
modifier: ABNORMAL
term:
id: GO:0006487
label: protein N-linked glycosylation
- member: UGGT1-congenital disorder of glycosylation
member_type: DISEASE
differentiating_mechanisms:
- description: >-
UGGT1 variants impair reglucosylation and ER retention of the
UDP-glucose:glycoprotein glucosyltransferase quality-control enzyme for
N-linked glycoproteins.
gene:
preferred_term: UGGT1
term:
id: hgnc:15663
label: UGGT1
biological_processes:
- preferred_term: protein folding in endoplasmic reticulum
modifier: ABNORMAL
term:
id: GO:0034975
label: protein folding in endoplasmic reticulum
notes: >-
This is an auditable work-package subgroup, not an attempt to replace the
broader Congenital Disorders of Glycosylation grouping or the MONDO hierarchy.